Related references
Note: Only part of the references are listed.Constitutive Clathrin-mediated Endocytosis of CTLA-4 Persists during T Cell Activation
Omar S. Qureshi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
The emerging role of CTLA4 as a cell-extrinsic regulator of T cell responses
Lucy S. K. Walker et al.
NATURE REVIEWS IMMUNOLOGY (2011)
Abatacept for Rheumatoid Arthritis: A Cochrane Systematic Review
Lara J. Maxwell et al.
JOURNAL OF RHEUMATOLOGY (2010)
Safety and Efficacy of the Selective Costimulation Modulator Abatacept in Patients with Rheumatoid Arthritis Receiving Background Methotrexate: A 5-year Extended Phase IIB Study
Rene Westhovens et al.
JOURNAL OF RHEUMATOLOGY (2009)
CD4+-CD25+ T regulatory cells suppress NK cell-mediated immunotherapy of cancer
MJ Smyth et al.
JOURNAL OF IMMUNOLOGY (2006)
Treatment of rheumatoid arthritis with the selective costimulation modulator abatacept - Twelve-month results of a phase IIb, double-blind, randomized, placebo-controlled trial
JM Kremer et al.
ARTHRITIS AND RHEUMATISM (2005)
Rational development of LEA29Y (belatacept), a high-affinity variant of CTLA4-lg with potent immunosuppressive properties
CP Larsen et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2005)
Proteomic analysis of human natural killer cells: insights on new potential NK immune functions
J Hanna et al.
MOLECULAR IMMUNOLOGY (2005)
Cross-talk between activated human NK cells and CD4+ T cells via OX40-OX40 ligand interactions
A Zingoni et al.
JOURNAL OF IMMUNOLOGY (2004)
CTLA-4-Ig regulates tryptophan catabolism in vivo
U Grohmann et al.
NATURE IMMUNOLOGY (2002)
Distinct role of CD80 and CD86 in the regulation of the activation of B cell and B cell lymphoma
S Suvas et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Share Paper
